CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Autologous Regeneration of Tissue (ART) devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03796988
NCT03796988N/ACompleted

Autologous Regeneration of Tissue (ART) for Wound Healing

University of Miami·interventional·Posted Jan 8, 2019·Updated Apr 23, 2025

In Brief

A clinical study evaluating Autologous Regeneration of Tissue (ART) device for Wound of Skin. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The purpose of this research study is to learn about a new device, Autologous Regeneration of Tissue (ART), for collecting skin grafts from participant's own skin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWound of Skin
CountriesUnited States
CollaboratorsMedline Industries

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 8, 2019
Enrollment StartSep 14, 2018
Primary CompletionMar 19, 2024
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 7.5 years ago

Interventions

Autologous Regeneration of Tissue (ART) devicedevice

This device will harvest hundreds of full-thickness columns of skin tissue (500 micrometer diameter) using single-needle, fluid-assisted harvesting technology.